# SLV-154 Treatment of Advanced Cancers

Source: https://onco.cc/trials/nct06771219/  
OnCo record `nct06771219` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of SLV-154 run by Solve Therapeutics, now recruiting.

## Summary

SLV-154 Treatment of Advanced Cancers is a phase 1 interventional study registered as NCT06771219 by Solve Therapeutics, with 250 participants planned, started 2025-05-14. Conditions recorded: Advanced Cancer, Advanced Solid Tumor and Metastatic Cancer. Interventions recorded: SLV-154.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06771219
- Phase: 1
- Setting: A Phase 1 Dose-Escalation/Expansion Study of SLV-154 in Subjects With Advanced Cancers
- Sponsor: Solve Therapeutics
- Enrolled: 250

## Sources

- ClinicalTrials.gov NCT06771219: https://clinicaltrials.gov/study/NCT06771219

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)
- drugs: [SLV-154](https://onco.cc/drugs/slv-154/)
- companies: [Solve Therapeutics](https://onco.cc/companies/solve-therapeutics/)

---
JSON: https://onco.cc/api/v1/entities/nct06771219.json